Saturday, August 20, 2016

TAFLOTAN (TAFLUPROST 0.0015%) LAUNCH IN KOTA KINABALU 

Santen Pharmaceutical Ltd., Japan, launched their new prostaglandin analogue, Taflotan, in Kota Kinabalu, Malaysia on 20th August 2016. The launch was accompanied by a talk by Dr Hoh Sek Tien from Mount Novena & Gleneagles Hospital, Singapore. 



No comments:

Post a Comment

DEFERIPRONE IN GLAUCOMA MANAGEMENT

  Currently, lowering of intra-ocular pressure (IOP) remains the main therapeutic option for the treatment of glaucoma. However, studies hav...